SCHEMBL4429771

SCHEMBL4429771

CN(C)CCN(C(=O)O)c1ccnc(N2CCc3cc([N+](=O)[O-])ccc32)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 4/20 0.46
GPR119 Q8TDV5 2/20 0.40
HTR2C P28335 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
ADRB2 P07550 2/20 0.36
ADRB1 P08588 2/20 0.36
ADRB3 P13945 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
DRD4 P21917 1/20 0.35
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
GAA P10253 2/20 0.33
TP53 P04637 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
EIF4E P06730 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3301776 0.89 ROCK1 (0.43) ROCK1GPR119HTR2CSIRT2MEN1
SCHEMBL4440927 0.86 GPR119 (0.41) ROCK1GPR119ADRB2ADRB1ADRB3
SCHEMBL3301780 0.83 ROCK1 (0.42) ROCK1GPR119HTR2CSIRT2MEN1
SCHEMBL4434092 0.83 ROCK1 (0.44) ROCK1HTR2CSIRT2MEN1KMT2A
SCHEMBL3295550 0.80 ROCK1 (0.45) ROCK1HTR2CADRB2ADRB1ADRB3
SCHEMBL3299789 0.76 ROCK1 (0.43) ROCK1GPR119HTR2CSIRT2MEN1
SCHEMBL3294743 0.75 ROCK1 (0.51) ROCK1HTR2CSIRT2ADRB2ADRB1
SCHEMBL3016231 0.74 ROCK1 (0.54) ROCK1HTR2CSIRT2KMT2ADRD4
SCHEMBL3301542 0.72 ROCK1 (0.54) ROCK1HTR2CMEN1KMT2AMKNK1
SCHEMBL3299787 0.71 ROCK1 (0.40) ROCK1GPR119HTR2CSIRT2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121600-B1 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INT (DE) 2012-07-18 EP disclosed
EP-2121600-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2009-11-25 EP disclosed
WO-2008099000-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-08-21 WO disclosed